Quantitative analysis of LP-BM5 murine leukemia retrovirus RNA using real-time RT-PCR

被引:24
作者
Cook, WJ
Green, KA
Obar, JJ
Green, WR
机构
[1] Dartmouth Coll Sch Med, Dept Microbiol & Immunol, Lebanon, NH 03756 USA
[2] Norris Cotton Canc Ctr, Lebanon, NH 03756 USA
关键词
murine immunodeficiency; LP-BM5; MuLV; gag RNA; BM5def; BM5eco; real-time RT-PCR;
D O I
10.1016/S0166-0934(02)00256-2
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Murine AIDS (MAIDS) develops in susceptible mouse strains after infection with the LP-BM5 murine leukemia virus (MuLV) complex that contains a mixture of defective (BM5def) and replication-competent viruses. While the BM5def virus is the causative agent in MAIDS, the replication-competent viruses in LP-BM5, including ecotropic MuLV (BM5eco), are required for BM5def propagation and thus function as helper viruses. We describe quantitative real-time RT-PCR assays for RNA encoded by the BM5def and BM5eco components of LP-BM5. The assays were used to standardize better the input doses of LP-BM5 viruses across viral preparations and to quantify BM5def and BM5eco gag RNA levels in spleen and blood cells from MAIDS-susceptible and -insusceptible infected mice. Spleens of MAIDS-susceptible infected mice harbored approximately similar levels of BM5def gag RNA as infected spleens of mice that are insusceptible to MAIDS due to lack of CD40. In contrast, the same infected spleens of CD40-deficient mice contained substantially higher (up to 10-fold) levels of BM5eco gag RNA compared with susceptible controls. Similar to that seen in spleen, infected blood of CD40-deficient mice contained similar levels of BM5def gag as susceptible strains, but increased levels (up to threefold) of BM5eco gag RNA. The assays described below can be used to characterize better the contributions of different functional viral components of the LP-BM5 mixture to the development of MAIDS. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:49 / 58
页数:10
相关论文
共 46 条
  • [1] *ABI PROT, 1997, USER B ABI PROT, V2, P11
  • [2] The CD40-TRAF6 axis controls affinity maturation and the generation of long-lived plasma cells
    Ahonen, CL
    Manning, EM
    Erickson, LD
    O'Connor, BP
    Lind, EF
    Pullen, SS
    Kehry, MR
    Noelle, RJ
    [J]. NATURE IMMUNOLOGY, 2002, 3 (05) : 451 - 456
  • [3] SEVERE IMMUNODEFICIENCY DISEASE INDUCED BY A DEFECTIVE MURINE LEUKEMIA-VIRUS
    AZIZ, DC
    HANNA, Z
    JOLICOEUR, P
    [J]. NATURE, 1989, 338 (6215) : 505 - 508
  • [4] BRUDEVI B, 2001, VET MICROBIOL, V83, P1
  • [5] ABROGATION OF RESISTANCE TO SEVERE MOUSEPOX IN C57BL/6 MICE INFECTED WITH LP-BM5 MURINE LEUKEMIA VIRUSES
    BULLER, RML
    YETTER, RA
    FREDRICKSON, TN
    MORSE, HC
    [J]. JOURNAL OF VIROLOGY, 1987, 61 (02) : 383 - 387
  • [6] B-CELLS ARE REQUIRED FOR INDUCTION OF T-CELL ABNORMALITIES IN A MURINE RETROVIRUS-INDUCED IMMUNODEFICIENCY SYNDROME
    CERNY, A
    HUGIN, AW
    HARDY, RR
    HAYAKAWA, K
    ZINKERNAGEL, RM
    MAKINO, M
    MORSE, HC
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (01) : 315 - 320
  • [7] DEFECTIVE VIRUS IS ASSOCIATED WITH INDUCTION OF MURINE RETROVIRUS-INDUCED IMMUNODEFICIENCY SYNDROME
    CHATTOPADHYAY, SK
    MORSE, HC
    MAKINO, M
    RUSCETTI, SK
    HARTLEY, JW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (10) : 3862 - 3866
  • [8] CHARACTERISTICS AND CONTRIBUTIONS OF DEFECTIVE, ECOTROPIC, AND MINK CELL FOCUS-INDUCING VIRUSES INVOLVED IN A RETROVIRUS-INDUCED IMMUNODEFICIENCY SYNDROME OF MICE
    CHATTOPADHYAY, SK
    SENGUPTA, DN
    FREDRICKSON, TN
    MORSE, HC
    HARTLEY, JW
    [J]. JOURNAL OF VIROLOGY, 1991, 65 (08) : 4232 - 4241
  • [9] Coffin John M., 1996, P763
  • [10] IN-VIVO TREATMENT WITH INTERLEUKIN-12 PROTECTS MICE FROM IMMUNE ABNORMALITIES OBSERVED DURING MURINE ACQUIRED-IMMUNODEFICIENCY-SYNDROME (MAIDS)
    GAZZINELLI, RT
    GIESE, NA
    MORSE, HC
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (06) : 2199 - 2208